The file's text, extracted by GovTribe without its formatting.
Attachment 3 Fiscal Year 2022 (FY22) Science Administration and Management (SAM) To Support the Congressionally Directed Medical Research Programs (CDMRP)
Overview: Under this task order for the BRAES contract, the Contractor shall provide general support for science administration and management, to include support and tasks applicable to all CDMRP programs. Pricing may include, but are not limited to senior management, systems administration, and office expenses and supplies. It is anticipated that all non-program-specific full and part time staff supporting the BRAES shall be consolidated onto this task order. Any support staff which are considered to be program specific shall be estimated and billed against the program specific task order, including but not limited to labor pricing for scientific review management, project management, and consumer reviewer administration.
Period of Performance: 12 months This task order shall be incrementally funded with no optional support.
Assumptions:
· The contractor is expected to support all anticipated FY21 research programs through the end of the review cycle or 29 May 2022, whichever comes first.
· Additional programs may be added/removed in the future but will be done via a modification.
· It is assumed that each of the programs below shall be supported by the contractor from the start to end of the program cycle, through final deliverable production and delivery.
· Estimates of pre-applications/proposals and full applications below are for estimation purposes only; more accurate estimates shall be provided in each program task order PWS.
· Anticipated number of funding opportunity announcements: 120-150
· Anticipated number of pre-applications to Program Announcements (PAs): 15,000-20,000
· Anticipated number of full research applications to PAs: 8,000-12,000
· Anticipated number of pre-applications to intramural solicitations: 650-800
· Anticipated number of research applications to intramural solicitations: 300-500
· Anticipated number of Broad Agency Announcements (BAAs): 5-10
· Anticipated number of pre-applications submitted to BAAs: 2,400-3,000
· Anticipated number of full applications submitted to BAAs: 550-750
| Anticipated FY21 CDMRP Research Programs |
| Anticipated Funding |
| Alcohol and Substance Abuse Disorders Research Program |
| $4 million (M) |
| Amyotrophic Lateral Sclerosis Research Program |
| $40 M |
| Autism Research Program |
| $15 M |
| Bone Marrow Failure Research Program |
| $3 M |
| Breast Cancer Research Program |
| $150 M |
| Chronic Pain Management Research Program |
| $15 M |
| Combat Readiness Medical Research Program |
| $10 M |
| Duchenne Muscular Dystrophy Research Program |
| $10 M |
| Epilepsy Research Program |
| $12 M |
| Gulf War Illness Research Program |
| $22 M |
| Hearing Restoration Research Program |
| $10 M |
| Joint Warfighter Medical Research Program |
| $40 M |
| Kidney Cancer Research Program |
| $50 M |
| Lung Cancer Research Program |
| $20 M |
| Lupus Research Program |
| $10 M |
| Melanoma Research Program |
| $30 M |
| Military Burn Research Program |
| $10 M |
| Multiple Sclerosis Research Program |
| $20 M |
| Neurofibromatosis Research Program |
| $15 M |
| Neurotoxin Exposure Treatment Parkinson’s Research Program |
| $16 M |
| Orthotics and Prosthetics Outcomes Research Program |
| $15 M |
| Ovarian Cancer Research Program |
| $35 M |
| Pancreatic Cancer Research Program |
| $10 M |
| Peer Reviewed Alzheimer’s Research Program |
| $15 M |
| Peer Reviewed Cancer Research Program |
| $115 M |
| Peer Reviewed Medical Research Program |
| $370 M |
| Peer Reviewed Orthopaedic Research Program |
| $30 M |
| Prostate Cancer Research Program |
| $110 M |
| Rare Cancers Research Program |
| $17.5 M |
| Reconstructive Transplant Research Program |
| $12 M |
| Scleroderma Research Program |
| $5 M |
| Spinal Cord Injury Research Program |
| $40 M |
| Tick-Borne Disease Research Program |
| $7 M |
| Traumatic Brain Injury/Psychological Health |
| $175 M |
| Tuberous Sclerosis Complex Research Program |
| $6 M |
| USAMRDC Broad Agency Announcement |
| Not applicable |
| Vision Research Program |
| $20 M |
Department of the Army Medical Command